Considering the rate‐limiting enzyme performs important biological function based on its protein levels, we then utilized a blinded external independent validation cohort (n = 90) to further investigate the RRM1, UCK2 and G6PD expression and their relationship with clinical outcome using immunohistochemistry (IHC) staining in HCC TMA. This evidence concerns the gene RRM1 and hepatocellular carcinoma.